BUZZ-Australia's <a href="https://laohu8.com/S/MGCLF">Argent BioPharma</a> set for best day in a year on AusCann deal** Argent Biopharma RGT.AX surges as much as 272.1% to A$0.32; marks biggest intra-day pct gain since August 21, 2024
** Stocks hits highest since October 24, 2024; eyes fourth straight session of gains
** Drug discovery firm signs binding term sheet to acquire cannabinoid-based therapeutics co AusCann Group for $15 million
** Co to secure Neuvis patented drug-delivery tech, FDA-facing epilepsy pre-clinical data, others under deal
** About 1.8 mln shares traded in stock's busiest day ever
** RGT last up 74.4%, trimming YTD losses to 26.5%
(Reporting by Ananya Verma in Bengaluru)
((ananya.verma@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.